CD39 improves survival in microbial sepsis by attenuating systemic inflammation - Wikidata - wikimedia - TriplyDB

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

http://www.wikidata.org/entity/Q34847971

about

Purinergic Signaling to Terminate TLR Responses in Macrophages Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing Purinergic Signaling and the Immune Response in Sepsis: A Review Role of purinergic signaling in experimental pneumococcal meningitis A2A adenosine receptors control pancreatic dysfunction in high-fat-diet induced obesity.Recent developments in severe sepsis research: from bench to bedside and back.Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury.Systemic Adenosine Triphosphate Impairs Neutrophil Chemotaxis and Host Defense in Sepsis.P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.Identification of key pathogenic genes of sepsis based on the Gene Expression Omnibus database.Ischemic Cerebroprotection Conferred by Myeloid Lineage-Restricted or Global CD39 Transgene Expression.The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes.Macrophage P2X4 receptors augment bacterial killing and protect against sepsis.Decrease of serum adenine nucleotide hydrolysis in an irritant contact dermatitis mice model: potential P2X7R involvement

P2860

Q26765923-1C6C67CD-9052-40BB-93F3-57CFEE39DA62 Q35998001-0C090590-D1E0-488C-9CCF-8D524054A2BF Q36923670-1EEE6741-C792-442B-94EE-D850D6965C6C Q37704497-68BAC785-3575-4EA7-B58B-995879EF07A3 Q38648091-FD8A74DC-D935-490A-95C3-AE58D65D89FF Q38724278-70874E57-A529-4899-815C-5A30EC2FC8B2 Q39331944-FEBA6782-EBDC-48CB-9895-BB1D0642B51A Q40567390-FEFEFD6D-6B07-4E2C-A3E0-64B7803A39D8 Q46479061-0A7AAE4F-5A8F-4FEF-B5A7-1CBA3C437C82 Q47275675-6963A16D-ADDE-4BD2-ABF1-015C008BB936 Q48230281-01354E01-AF96-4EBD-B3C6-6D9FD1228B93 Q50202418-56F53BBD-AF8A-4B55-A89B-D5616E6FCD92 Q52768241-B8928D79-8BC5-4022-9D2E-CB6207C00265 Q54217234-E2C6CE77-F5B8-48EC-AA5F-82BE16724C80 Q55381414-111756B0-E923-4923-8F9E-59C6A10B00F1 Q58310808-56CDB66F-A769-44D7-B0CB-15109757D152

P2860

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

http://www.wikidata.org/entity/Q34847971

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@ast

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@en

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@nl

type

label

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@ast

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@en

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@nl

prefLabel

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@ast

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@en

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@nl

P1433

Q34847971-1ED70A4D-C2D7-4D12-98D8-98A26E2CB61C

P1476

Q34847971-ABD22C70-3DD5-496A-90EF-6E765DAE1B42

P2093

Q34847971-026F9419-E535-43FF-914D-8B84472690AE

Q34847971-1182B384-E87E-4B3A-A4F1-607480EEB1C6

Q34847971-13845FE2-2ACE-4872-A5AC-E520B63B1C87

Q34847971-1824A693-F6E1-4642-8D5C-1B5737A70CF0

Q34847971-1A60751C-CA09-4F26-8B7C-8826B2AF13AE

Q34847971-2366D4C8-25A1-4690-8EBB-95F427D49565

Q34847971-38F1E111-D156-42B5-8FF2-ADD4EA029022

Q34847971-7FA35D73-C2C0-44F7-BB5A-FE86C70A9834

Q34847971-B5BCBE2B-FDD7-4520-9AA0-7A97D4EEA5A4

Q34847971-EC30C065-05EE-4BC1-AADB-4D66379A8885

P2860

Q34847971-0848AF13-4FF3-4E31-BF6A-E55CDDD2B783

Q34847971-138D2DED-9F2A-4084-A8A5-D4F665377CB1

Q34847971-21ED4466-14F8-4DC0-88D3-69C935ABFB6B

Q34847971-257647B7-F0BC-437C-B18E-0AACD5497409

Q34847971-29F7E009-6363-4611-BD42-E13A6EF3CC81

Q34847971-2A31E2DC-935C-46C0-BD6F-CF7D536BF4D4

Q34847971-305B6E6D-E5A6-4EF6-BF48-64065BA964B3

Q34847971-3DF165EA-6CE9-492A-A998-A11913D14EF4

Q34847971-4370A6BF-4F50-4F19-B7A8-ECBFA31CCC68

Q34847971-48028FDE-1EC3-41D9-8378-986971FFA8CD

P304

Q34847971-2DCDD616-0F5E-47A6-9715-9A37A98AA7CB

P31

Q34847971-A0899973-FCEB-41AE-BC92-6207A124325E

P356

Q34847971-27D6D8A0-CDBB-4903-A453-46AE87BDEC8E

P407

Q34847971-72ECD826-A766-45AC-A7B7-1DC692D19073

P433

Q34847971-0902A490-D454-4A9D-94F6-B584E22CF9D3

P478

Q34847971-94A95260-26C2-477B-B411-11536D609245

P50

Q34847971-C3785A4B-BE7E-43BE-8F35-02001F77C433

P577

Q34847971-A401055A-29DC-479F-B527-4F5E1A1ADF34

P698

Q34847971-57AED92A-1CF8-49FD-819D-0F200171E3C4

P921

Q34847971-2B8021F2-EAEF-4DE8-853A-00C62270B357

Q34847971-4C9D6B16-34FD-4911-9D22-3D9FC7FF36A3

P932

Q34847971-D8978A21-550D-40B2-9B94-3BE74F94E180

P356

P1433

P1476

CD39 improves survival in microbial sepsis by attenuating systemic inflammation

@en

P2093

Balázs Csóka

http://www.w3.org/2001/XMLSchema#string

Balázs Koscsó

http://www.w3.org/2001/XMLSchema#string

Endre Kókai

http://www.w3.org/2001/XMLSchema#string

György Haskó

http://www.w3.org/2001/XMLSchema#string

Gábor Törő

http://www.w3.org/2001/XMLSchema#string

Katalin Erdélyi

http://www.w3.org/2001/XMLSchema#string

Keiichi Enjyoji

http://www.w3.org/2001/XMLSchema#string

Rolando H Rolandelli

http://www.w3.org/2001/XMLSchema#string

Simon C Robson

http://www.w3.org/2001/XMLSchema#string

Zoltán H Németh

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Identification and characterization of CD39/vascular ATP diphosphohydrolase

ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia.

The reno-vascular A2B adenosine receptor protects the kidney from ischemia

Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis

The epidemiology of sepsis in the United States from 1979 through 2000

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

The pathophysiology and treatment of sepsis

A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis.

P304

25-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.14-253567

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25318479

http://www.w3.org/2001/XMLSchema#string

P921

P932

4285550

http://www.w3.org/2001/XMLSchema#string